Aeterna Zentaris
AEZS
#10198
Rank
A$26.36 M
Marketcap
A$8.61
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$3.08. In 2022 the company made an earnings per share (EPS) of A-$7.05 a decrease over its 2021 EPS that were of A-$2.74.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$7.05157.14%
2021A-$2.74-41.48%
2020A-$4.68-64.46%
2019A-$13.17-240%
2018A$9.41-122.32%
2017A-$42.15-53.53%
2016A-$90.71-86.71%
2015A-$682.74-35.21%
2014A-$1,054-216.67%
2013A$903.30-123.3%
2012A-$3,877-40.8%
2011A-$6,549-6.45%
2010A-$7,001-27.91%
2009A-$9,710-61.61%
2008A-$25,29283.61%
2007A-$13,775-195.31%
2006A$14,453178.26%
2005A$5,194-330%
2004A-$2,258-80.05%
2003A-$11,31917.78%
2002A-$9,611515.93%
2001A-$1,560-68.6%
2000A-$4,970119.62%
1999A-$2,263-3.63%
1998A-$2,348

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
A-$0.54-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.08-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$4.47-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.58-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
A$7.36-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA